Multiple chamber container
    12.
    发明授权
    Multiple chamber container 失效
    多室容器

    公开(公告)号:US5431496A

    公开(公告)日:1995-07-11

    申请号:US295363

    申请日:1994-08-24

    摘要: A multiple chamber container for mixing and administering a plurality of products. The container has at least two chambers separated by a seal line. A frangible connector is situated between the two chambers for mixing the products contained within the chambers as desired. Each chamber has at least one port for filling of product into the chamber. The ports are located on the same exterior side of the container such that the chambers can be filled without folding the bag and by using existing filling equipment.

    摘要翻译: 一种用于混合和施用多种产品的多室容器。 容器具有至少两个由密封线隔开的室。 一个易碎连接器位于两个室之间,用于根据需要混合容纳在室内的产品。 每个室具有至少一个用于将产品填充到室中的端口。 端口位于容器的相同的外侧,使得可以在不折叠袋子的情况下填充室并且使用现有的填充设备。

    Sterilized peritoneal dialysis solutions containing heparin
    13.
    发明申请
    Sterilized peritoneal dialysis solutions containing heparin 审中-公开
    含有肝素的无菌腹膜透析溶液

    公开(公告)号:US20070155672A1

    公开(公告)日:2007-07-05

    申请号:US11326236

    申请日:2006-01-05

    摘要: Sterilized dialysis solutions containing glycosaminoglycan, for example Heparin, and methods of making and using same are provided. In an embodiment, the present invention provides different peritoneal dialysis solutions containing Heparin that are stable under sterilization conditions. For example, the solutions are designed to provide all-in-one, ready-to-use sterilized solutions for peritoneal dialysis.

    摘要翻译: 提供了含有糖胺聚糖的灭菌透析溶液,例如肝素,以及制备和使用它们的方法。 在一个实施方案中,本发明提供了在灭菌条件下稳定的含有肝素的不同的腹膜透析溶液。 例如,该解决方案被设计为提供一体化的即用型无菌溶液用于腹膜透析。

    Peritoneal dialysis solutions with polypeptides
    15.
    发明授权
    Peritoneal dialysis solutions with polypeptides 失效
    具多肽的腹膜透析液

    公开(公告)号:US06380163B1

    公开(公告)日:2002-04-30

    申请号:US07995106

    申请日:1992-12-22

    IPC分类号: A61K3808

    摘要: The present invention provides an improved dialysis solution. The improved dialysis solution provides for the use of specific polypeptides as an osmotic agent with an additional osmotic agent such as dextrose. To this end, the present invention provides, in an embodiment, a peritoneal dialysis solution comprising as osmotic agents approximately 0.25 to about 4.0% (w/v) polypeptides and approximately 0.5% to about 4.0% (w/v) dextrose. The polypeptides have well defined characteristics.

    摘要翻译: 本发明提供了一种改进的透析溶液。 改进的透析溶液提供使用特定多肽作为渗透剂与另外的渗透剂如葡萄糖。 为此,在一个实施方案中,本发明提供包含约0.25至约4.0%(w / v)多肽和约0.5%至约4.0%(w / v)葡萄糖的渗透剂的腹膜透析溶液。 多肽具有明确的特征。

    Bicarbonate-based peritoneal dialysis solutions
    18.
    发明申请
    Bicarbonate-based peritoneal dialysis solutions 审中-公开
    基于碳酸氢盐的腹膜透析液

    公开(公告)号:US20050276868A1

    公开(公告)日:2005-12-15

    申请号:US10866206

    申请日:2004-06-10

    摘要: Dialysis solutions and methods of manufacturing and using same are provided. The dialysis solution at least includes three solution parts that are separately stored and sterilized at an effective pH to promote the stabilization of the solution parts including a pH-sensitive solution part that has, for example, a pH-sensitive osmotic agent, such as a glucose polymer. The solution parts are admixed to form a ready-to-use solution with a physiologically acceptable pH.

    摘要翻译: 提供了透析溶液及其制造和使用方法。 所述透析溶液至少包括三个溶液部分,其在有效pH下分开存储和灭菌,以促进溶液部分的稳定化,包括pH敏感溶液部分,其具有例如pH敏感性渗透剂,例如 葡萄糖聚合物。 将溶液部分混合以形成具有生理上可接受的pH的即用型溶液。

    Peritoneal dialysis solutions with polypeptides
    19.
    发明授权
    Peritoneal dialysis solutions with polypeptides 失效
    具多肽的腹膜透析液

    公开(公告)号:US06730660B2

    公开(公告)日:2004-05-04

    申请号:US09909733

    申请日:2001-07-20

    IPC分类号: A61K3806

    摘要: The present invention provides an improved dialysis solution. The improved dialysis solution provides for the use of specific polypeptides as an osmotic agent with an additional osmotic agent such as dextrose. To this end, the present invention provides, in an embodiment, a peritoneal dialysis solution comprising as osmotic agents approximately 0.25 to about 4.0% (w/v) polypeptides and approximately 0.5% to about 4.0% (w/v) dextrose. The polypeptides have well defined characteristics.

    摘要翻译: 本发明提供了一种改进的透析溶液。 改进的透析溶液提供使用特定多肽作为渗透剂与另外的渗透剂如葡萄糖。 为此,在一个实施方案中,本发明提供包含约0.25至约4.0%(w / v)多肽和约0.5%至约4.0%(w / v)葡萄糖的渗透剂的腹膜透析溶液。 多肽具有明确的特征。

    Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
    20.
    发明授权
    Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy 失效
    碳酸氢盐溶液在两部分用于腹膜透析或连续肾替代治疗中的替代

    公开(公告)号:US06309673B1

    公开(公告)日:2001-10-30

    申请号:US09393743

    申请日:1999-09-10

    IPC分类号: A61K3300

    摘要: The present invention provides devices and methods for stabilizing bicarbonate-based solutions for peritoneal dialysis or hemofiltration. The bicarbonate-based solutions of the present invention are formulated and stored in at least two parts—an alkaline bicarbonate concentrate and an acidic concentrate. The alkaline bicarbonate concentrate is adjusted to have a pH of about 8.6 to 10.0. The acidic concentrate is adjusted to have a stable, acidic pH ranging from about 1.0 to 3.0. Upon mixing, although some variation in the pH of the mixed bicarbonate solution exists, the inventors have discovered that with the appropriate selection of the parameters of the concentrates, the pH of the mixed solution is always within an acceptable physiological range.

    摘要翻译: 本发明提供用于稳定用于腹膜透析或血液滤过的基于碳酸氢根的溶液的装置和方法。 将本发明的基于碳酸氢盐的溶液配制并储存在至少两部分中 - 碱性碳酸氢盐浓缩物和酸性浓缩物。 将碱式碳酸氢盐浓缩物调节至约8.6至10.0的pH。 将酸性浓缩物调节至具有约1.0至3.0的稳定的酸性pH。 在混合时,虽然存在混合碳酸氢盐溶液的pH的一些变化,本发明人已经发现,通过适当选择浓缩物的参数,混合溶液的pH总是在可接受的生理范围内。